August 30, 2014 2:44 PM ET

Biotechnology

Company Overview of BioVascular, Inc.

Executive Profile

Paul F. Glidden Ph.D.

Vice President of Development and Director, BioVascular, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Paul F. Glidden, PhD, founded BioVascular, Inc. and serves as its Vice President of Development. Dr. Glidden served as the Vice President, Development of Angiosyn, Inc. Dr. Glidden served as Director of Pharmacology and Toxicology of ISTA Pharmaceuticals. From 1989 to 2000, Dr. Glidden served at Alpha Therapeutics developing new chemical entities for cardiovascular therapies, including critical limb ischemia and intermittent claudication, new molecular entities for the ...

Corporate Headquarters

12230 El Camino Real
San Diego, California 92130

United States

Phone: 858-455-5000
Fax: 858-455-6200

Board Members Memberships

Vice President of Development and Director

Education

BS
Oregon State University
PhD
University of California, Irvine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BioVascular, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.